(Q51549773)

6 April 2018

title

The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer. (English)

1 reference

6 April 2018

2

Andrea Mariani

1 reference

6 April 2018

Michaela E. McGree

5

object named as

Michaela E McGree

1 reference

6 April 2018

Amy L. Weaver

4

object named as

Amy L Weaver

1 reference

6 April 2018

author name string

Jamie N Bakkum-Gamez

1

1 reference

6 April 2018

Sean C Dowdy

3

1 reference

6 April 2018

William A Cliby

6

1 reference

6 April 2018

Bobbie S Gostout

7

1 reference

6 April 2018

C Robert Stanhope

8

1 reference

6 April 2018

Timothy O Wilson

9

1 reference

6 April 2018

Karl C Podratz

10

1 reference

6 April 2018

language of work or name

English

0 references

publication date

13 July 2011

1 reference

6 April 2018

published in

Gynecologic Oncology

1 reference

6 April 2018

volume

123

1 reference

6 April 2018

issue

1

1 reference

6 April 2018

page(s)

58-64

1 reference

6 April 2018

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Staging error does not explain the relationship between the number of lymph nodes in a colon cancer specimen and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Prognostic variables in thoracic esophageal squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Survival impact of lymph node dissection in endometrial adenocarcinoma: a surveillance, epidemiology, and end results analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for locally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Detection of occult lymph node metastases in locally advanced node-negative prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Quantitative detection of micrometastases in pelvic lymph nodes in patients with clinically localized prostate cancer by real-time reverse transcriptase-PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Diagnosing occult tumour cells and their predictive value in sentinel nodes of histologically negative patients with colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Cytokeratin staining of resected lymph nodes may improve the sensitivity of surgical staging for endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Analysis of FIGO Stage IIIc endometrial cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Endometrial carcinoma: paraaortic dissemination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Predictors of lymphatic failure in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Hematogenous dissemination in corpus cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Endometrial cancer: predictors of peritoneal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Predictors of vaginal relapse in stage I endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

The comparative assessment and improvement of quality of surgical care in the Department of Veterans Affairs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Extraperitoneal endosurgical aortic and common iliac dissection in the staging of bulky or advanced cervical carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Extra-peritoneal laparoscopic para-aortic lymphadenectomy--a prospective cohort study of 293 patients with endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

A process for measuring the quality of cancer care: the Quality Oncology Practice Initiative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Quality improvement in gynecologic surgery: the new frontier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Laparoscopic pelvic and paraaortic lymph node dissection: analysis of the first 100 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Minimally invasive comprehensive surgical staging for endometrial cancer: Robotics or laparoscopy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

A comparative detail analysis of the learning curve and surgical outcome for robotic hysterectomy with lymphadenectomy versus laparoscopic hysterectomy with lymphadenectomy in treatment of endometrial cancer: a case-matched controlled study of the f

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.018

10.1016/J.YGYNO.2011.06.018

7 January 2021

Identifiers

DOI

1 reference

6 April 2018

1 reference

6 April 2018